Back

Is the HNF4A gene variant paradoxically associated with better prognostic in CAD patients?

1 September 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease: genetic determinants and molecular phenotyping Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Debora Sa

Hospital Dr. Nelio Mendonca, Funchal (Portugal)

4 More presentations in this session

Presentation thumbnail
Circulating ACE2 and the association of endothelial progenitor cell in CAD patients
Doctor Y. Lu (Taichung, TW)
Abstract Slides Video
Presentation thumbnail
Aspirin inhibits atherosclerosis through macrophage pyroptosis by interacting with Lactobacillus johnsonii and its metabolite butyrate
Doctor H. Rui (Xi'an, CN)
Abstract Slides Video
Presentation thumbnail
Awareness and perceptions of cardiologists towards systemic inflammation in atherosclerotic cardiovascular disease: A multi-national survey across 5 geographical regional sub-groups
Professor A. Catapano (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Coronary Computed Tomographic Angiography (CCTA) in non-ST elevation acute coronary syndromes
Doctor I. Chapman (Buenos Aires, AR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease: genetic determinants and molecular phenotyping

The Event

Event poster

ESC Congress 2024

1 September 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
TCF21 gene and cardiovascular events in a coronary population
thumbnail
Congress Presentation
Does the LPA genotype have a role in coronary artery disease risk beyond Lp(a) values?
thumbnail
Congress Presentation
Genetic predictors of unfavorable prognosis in patients with low and moderate cardiovascular risk with high adherence to treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources